BCL2, BCL2 apoptosis regulator, 596

N. diseases: 1456; N. variants: 27
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0008370
Disease: Cholestasis
Cholestasis
0.010 AlteredExpression disease BEFREE In conclusion, cholestasis increased the expression of Bax and decreased the expression of Bcl-2, and this effect may have related to enhanced susceptibility of mitochondrial pathways following oxidative stress. 31773435 2020
CUI: C0162836
Disease: Hidradenitis Suppurativa
Hidradenitis Suppurativa
0.010 AlteredExpression disease BEFREE A GENETIC VARIANT IN THE BCL2 GENE ASSOCIATES WITH ADALIMUMAB RESPONSE IN HIDRADENITIS SUPPURATIVA CLINICAL TRIALS AND REGULATES EXPRESSION OF BCL2. 31465739 2020
CUI: C0282193
Disease: Iron Overload
Iron Overload
0.010 AlteredExpression disease BEFREE After 7 weeks, compared with the control group, the zinc and magnesium contents; superoxide dismutase, glutathione peroxidase, and catalase activities; and synaptophysin and Bcl-2 gene expressions in the iron overload group were significantly decreased, whereas the iron, calcium contents, and malondialdehyde contents; TUNEL-positive cell numbers; and Fas and Bax gene expressions were significantly increased. 31236816 2020
CUI: C0393484
Disease: Rasmussen Syndrome
Rasmussen Syndrome
0.010 Biomarker disease BEFREE Double staining revealed colocalization of A2ARs and Bcl-2 in RE lesions. 31353670 2020
CUI: C1334633
Disease: Mature B-Cell Neoplasm
Mature B-Cell Neoplasm
0.010 GeneticVariation disease BEFREE Follicular lymphoma (FL) is an indolent, mature B-cell neoplasm classically characterised by the t(14;18)(q32;q21) with constitutive overexpression of the anti-apoptotic protein, BCL2. 31791624 2020
CUI: C2930868
Disease: Rasmussen subacute encephalitis
Rasmussen subacute encephalitis
0.010 Biomarker disease BEFREE Double staining revealed colocalization of A2ARs and Bcl-2 in RE lesions. 31353670 2020
CUI: C0005944
Disease: Metabolic Bone Disorder
Metabolic Bone Disorder
0.010 Biomarker group BEFREE An important osteoclastogenesis-regulating signaling pathway (JNK1-Bcl-2-Beclin1-autophagy activation) was identified, which provides novel potential targets for the clinical therapy of metabolic bone diseases.-Ke, D., Ji, L., Wang, Y., Fu, X., Chen, J., Wang, F., Zhao, D., Xue, Y., Lan, X., Hou, J. JNK1 regulates RANKL-induced osteoclastogenesis <i>via</i> activation of a novel Bcl-2-Beclin1-autophagy pathway. 31295022 2019
CUI: C0013238
Disease: Dry Eye Syndromes
Dry Eye Syndromes
0.010 Biomarker disease BEFREE Effects of Vitamin A on Expressions of Apoptosis Genes Bax and Bcl-2 in Epithelial Cells of Corneal Tissues Induced by Benzalkonium Chloride in Mice with Dry Eye. 31257361 2019
CUI: C0018553
Disease: Hamartoma Syndrome, Multiple
Hamartoma Syndrome, Multiple
0.010 AlteredExpression disease BEFREE The levels of kidney function markers, kidney injury molecules-1 (KIM-1), metallothionein, lipid peroxidation, nitric oxide, tumor necrosis factor-α, interleukin-1β, and the apoptosis regulators Bax and caspases-3 also increased significantly in the renal tissue of Cd-treated mice, whereas the levels of glutathione, antioxidant enzyme activities, and the apoptosis inhibitor Bcl-2 were significantly reduced in the renal tissue of Cd-treated group. 30967588 2019
CUI: C0018790
Disease: Cardiac Arrest
Cardiac Arrest
0.010 AlteredExpression disease BEFREE Furthermore, B‑cell lymphoma 2 (Bcl‑2)‑associated X protein (Bax) and caspase‑3 levels were elevated and Bcl‑2 levels were decreased in the left myocardium following APE‑CA and ROSC. 30816437 2019
CUI: C0019151
Disease: Hepatic Encephalopathy
Hepatic Encephalopathy
0.010 Biomarker disease BEFREE Western blot data demonstrated that administration of MI could regulate the redox-related expressions of Txnip, Trx, Nrf2, HO-1, p-IκB-α, p-NF-κB, Caspase-3, Caspase-9, Bax and Bcl-2 in EPI-stimulated hepatic encephalopathy (HE). 31351363 2019
CUI: C0023804
Disease: Lipomatosis, Multiple Symmetrical
Lipomatosis, Multiple Symmetrical
0.010 Biomarker disease BEFREE When combined with a pro-apoptotic agent/B Cell Lymphoma 2 (BCL2) inhibitor, the effectiveness of the combination regimen was super-additive compared to either treatment alone and was selective for MSL cancers. 31448050 2019
CUI: C0024205
Disease: Lymphadenitis
Lymphadenitis
0.010 AlteredExpression disease BEFREE Patients with C. burnetii lymphadenitis presented significant elevated levels of BCL2 and ETS1 mRNAs. 31181104 2019
CUI: C0026948
Disease: Mycosis Fungoides
Mycosis Fungoides
0.010 AlteredExpression group BEFREE In the present study, BCL-2 and Survivin showed strong positive expression on neoplastic lymphocytes in all cases of MF regardless of their stage. 31648231 2019
CUI: C0030193
Disease: Pain
Pain
0.010 GeneticVariation phenotype BEFREE We generated a focused library of compounds towards Bcl-2 interface, screened the 8270 compounds and identified top hits for seven families upon fine filtering with PAINS algorithm, features, SAR mapping, synthetic accessibility and similarity search. 31210110 2019
CUI: C0042029
Disease: Urinary tract infection
Urinary tract infection
0.010 AlteredExpression group BEFREE In addition, treatment with UTI significantly decreased the expression levels of Bcl‑2, Bcl‑extra large and Bcl‑associated X protein. 30664153 2019
CUI: C0085612
Disease: Ventricular arrhythmia
Ventricular arrhythmia
0.010 AlteredExpression disease BEFREE Incidence of VAs, serum levels of malondialdehyde (MDA) and superoxide dismutase (SOD), expression of connexin (Cx43), Bcl-2, Bax, caspase-3, tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), and high mobility group box (HMGB)1 were compared. 30516302 2019
CUI: C0149871
Disease: Deep Vein Thrombosis
Deep Vein Thrombosis
0.010 AlteredExpression disease BEFREE It was also revealed that Bcl-2 was a direct target of miR-195-5p, and that Bcl-2 was downregulated in the blood of patients with DVT. miR-195-5p downregulation promoted cell viability and inhibited the apoptosis of human umbilical vein endothelial cells (HUVECs). miR-195-5p upregulation inhibited cell viability and increased the apoptosis of HUVECs. 31807149 2019
CUI: C0155877
Disease: Allergic asthma
Allergic asthma
0.010 Biomarker disease BEFREE The nanoformulated Bcl-2 inhibitor Nf-ABT-199 accumulates in the mitochondria of inflammatory cells and efficiently alleviates allergic asthma. 30500724 2019
CUI: C0175701
Disease: Aarskog syndrome
Aarskog syndrome
0.010 AlteredExpression disease BEFREE AAS treated MCF-7 and SAS cells showed downregulation of Bcl-2 protein expression in comparison to their control cells. 30391273 2019
CUI: C0206062
Disease: Lung Diseases, Interstitial
Lung Diseases, Interstitial
0.010 Biomarker group BEFREE Antiapoptotic Bcl-2 was linked with exclusion of apoptosis from B cell follicles in CVID ILD and increased survival of naive CVID B cells cultured with BAFF. 30843876 2019
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.010 Biomarker phenotype BEFREE Grape seed proanthocyanidin extract and insulin prevents cognitive decline in type 1 diabetic rat by impacting Bcl-2 and Bax in the prefrontal cortex. 30284105 2019
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.010 AlteredExpression group BEFREE Moreover, we found enhanced expression of Bcl2-associated X, apoptosis regulator (Bax), and cleaved caspase-3, and reduced expression of B-cell lymphoma 2 (Bcl-2) in the LPS-treated group, which were markedly reversed in the LPS + caffeine co-treated group. 31717470 2019
CUI: C0264716
Disease: Chronic heart failure
Chronic heart failure
0.010 AlteredExpression disease BEFREE Serum Levels of Inflammatory Cytokines and Expression of BCL2 and BAX mRNA in Peripheral Blood Mononuclear Cells and in Patients with Chronic Heart Failure. 30968846 2019
CUI: C0274294
Disease: Chronic mountain sickness
Chronic mountain sickness
0.010 AlteredExpression disease BEFREE In conclusion, erythroblasts apoptosis is decreased due to the regulation of the expression of Bcl-2 family members in the erythroblasts of CMS patients. 30683541 2019